| [1] |
Kraepelin E. Dementia praecox and paraphrenia[M]. Edinburgh: Livingston, 1919.
|
| [2] |
Kasanin J. The acute schizoaffective psychoses. 1933 [J]. Am J Psychiatry, 1994, 151(6 Suppl): 144-154.
|
| [3] |
Heckers S. Diagnostic criteria for schizoaffective disorder [J]. Expert Rev Neurother, 2012, 12(1): 1-3.
|
| [4] |
Abrams DJ, Rojas DC, Arciniegas DB. Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature [J]. Neuropsychiatr Dis Treat, 2008, 4(6): 1089-1109.
|
| [5] |
Cosgrove VE, Suppes T. Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia [J]. BMC Med, 2013, 11: 127.
|
| [6] |
Moeini M, Khaleghi A, Amiri N, et al. Quantitative electroencephalogram(QEEG) Spectrum Analysis of Patients with Schizoaffective Disorder Compared to Normal Subjects [J]. Iran J Psychiatry, 2014, 9(4): 216-221.
|
| [7] |
Landin-Romero R, Canales-Rodríguez EJ, Kumfor F, et al. Surface-based brain morphometry and diffusion tensor imaging in schizoaffective disorder [J]. Aust N Z J Psychiatry, 2017, 51(1): 42-54.
|
| [8] |
Amann BL, Canales-Rodríguez EJ, Madre M, et al. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder [J]. Acta Psychiatr Scand, 2016, 133(1): 23-33.
|
| [9] |
Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis [J]. Schizophr Res, 2010, 117(1): 1-12.
|
| [10] |
Bora E, Fornito A, Radua J, et al. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis [J]. Schizophr Res, 2011, 127(1-3): 46-57.
|
| [11] |
Murru A, Pacchiarotti I, Nivoli AM, et al. What we know and what we don’t know about the treatment of schizoaffective disorder [J]. Eur Neuropsychopharmacol, 2011, 21(9): 680-690.
|
| [12] |
Cascade E, Kalali AH, Buckley P. Treatment of schizoaffective disorder [J]. Psychiatry(Edgmont), 2009, 6(3): 15-17.
|
| [13] |
Lindenmayer JP, Citrome L, Khan A, et al. A randomized, double-blind, parallel-group, fixed-dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder [J]. J Clin Psychopharmacol, 2011, 31(2): 160-168.
|
| [14] |
Lindenmayer JP, Kaur A. Antipsychotic management of schizoaffective disorder: a review [J]. Drugs, 2016, 76(5): 589-604.
|
| [15] |
Zimbroff D, Warrington L, Loebel A, et al. Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study [J]. Int Clin Psychopharmacol, 2007, 22(6): 363-370.
|
| [16] |
Cheniaux E, Landeira-Fernandez J, Lessa TL, et al. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders [J]. J Affect Disord, 2008, 106(3): 209-217.
|
| [17] |
Harrow M, Grossman LS, Herbener ES, et al. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms [J]. Br J Psychiatry, 2000, 177: 421-426.
|
| [18] |
Azorin JM, Kaladjian A, Fakra E.[Current issues on schizoaffective disorder] [J]. Encephale, 2005, 31(3): 359-365.
|
| [19] |
Keck PE, McElroy SL, Strakowski SM, et al. Pharmacologic treatment of schizoaffective disorder [J]. Psychopharmacology(Berl), 1994, 114(4): 529-538.
|
| [20] |
Levinson DF, Umapathy C, Musthaq M. Treatment of schizoaffective disorder and schizophrenia with mood symptoms [J]. Am J Psychiatry, 1999, 156(8): 1138-1148.
|
| [21] |
Möller HJ, Jäger M, Riedel M, et al. The Munich 15-year follow-up study(MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity [J]. Eur Arch Psychiatry Clin Neurosci, 2010, 260(5): 367-384.
|